---

ISHLT GUIDELINES

As part of our mission, ISHLT engages in the regular development of guidelines regarding end-stage heart disease, end-stage lung disease, heart transplantation, and lung transplantation.  A complete list of the guidelines and recommendations ISHLT has either published, co-authored, and/or endorsed is listed below, organized by date of publication.  Free access to the full text of most of the below documents is available by clicking on the titles.

2009

• ISHLT Guide to Guidelines Development (PDF).  This is the document which all ISHLT-developed standards and guidelines are required to follow.
• Generic Drug Immunosuppression in Thoracic Transplantation: An ISHLT Educational Advisory (pdf)
• 2009 ESC/ERS Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension

2006

• Rationale and Process: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates-2006
• Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates-2006
• Optimal Pharmacologic and Non-pharmacologic Management of Cardiac Transplant Candidates: Approaches to Be Considered Prior to Transplant Evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates-2006
• Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates-2006
  
  International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update - A Consensus Report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
• Present Status of Research on Psychosocial Outcomes in Cardiothoracic Transplantation: Review and Recommendations for the Field

2005

• Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection
• Primary Lung Graft Dysfunction Part I: Introduction and Methods
• Primary Lung Graft Dysfunction Part II: Definition. A Consensus Statement of the International Society for Heart and Lung Transplantation
• Primary Lung Graft Dysfunction Part III: Donor Related Risk Factors and Markers
  
• Primary Lung Graft Dysfunction Part IV: Recipient-Related Risk Factors and Markers
• Primary Lung Graft Dysfunction Part V: Predictors and Outcomes
• Primary Lung Graft Dysfunction Part VI: Treatment
• Scientific Registry of the International Society for Heart and Lung Transplantation: Introduction to the 2005 Annual Reports

2004

• Practice Guidelines for Management of Heart Failure in Children

2003

• A Review of Lung Transplant Donor Acceptability Criteria (a consensus report of the ISHLT Pulmonary Council)
• Destination Mechanical Circulatory Support: Proposal for Clinical Standards

2002

• Maximizing Use of Organs Recovered from the Cadaver Donor: Cardiac Recommendations
• Bronchiolitis Obliterans Syndrome 2001: an Update of the Diagnostic Criteria
• ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary

2000

• Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the Present Status of Xenotransplantation and its Potential Role in the Treatment of End-Stage Cardiac and Pulmonary Diseases

1998

• International Guidelines for the Selection of Lung Transplant Candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.

1996

• Revision of the 1990 Working Formulation for the Classification of Pulmonary Allograft Rejection: Lung Rejection Study Group.
• A Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart and Lung Rejection: Lung Rejection Study Group, The International Society for Heart Transplantation
• A Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart and Lung Rejection: Heart Rejection Study Group, The International Society for Heart Transplantation

To order reprints of articles published in the Journal of Heart and Lung Transplantation, contact Elsevier Science, Inc., Tel: 212-633-3874.